Economic burden of functional and organic mitral valve regurgitation

Archives of Cardiovascular Diseases

Volumn 108, Issue 2, 2015, Pages 88-96

  Trochu, Jean Noël ^a   Le Tourneau, Thierry ^a   Obadia, Jean François ^b   Caranhac, Gilbert ^c   Beresniak, Ariel ^d,e  

^a L INSTITUT DU THORAX   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c Hox Com Analytiques ^*  (France)

^d DATA MINING INTERNATIONAL   (Switzerland)

^e et Institut de recherche et documentation en économie de la santé   (France)

Author keywords

Health economic costs; Heart failure; Mitral regurgitation; Mitral valve; Pharmacology

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COST OF ILLNESS; ECONOMIC ASPECT; FEMALE; HEALTH CARE UTILIZATION; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; SURGICAL PATIENT; TREATMENT OUTCOME; COMORBIDITY; ECONOMICS; FRANCE; HOSPITAL COST; MITRAL VALVE INSUFFICIENCY; MORTALITY; RETROSPECTIVE STUDY;

AGED; COMORBIDITY; COST OF ILLNESS; FEMALE; FRANCE; HEART FAILURE; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 84923826436     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2014.09.008     Document Type: Article

References (30)

1. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231.
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
3. Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vaha-nian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol 2007;32:609-61.
4. Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace 2011;13(Suppl. 2):ii13-7.
5. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Ghe-orghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003;91:360-2.
6. Varadarajan P, Sharma S, Heywood JT, Pai RG. High prevalence of clinically silent severe mitral regurgitation in patients with heart failure: role for echocardiography. J Am Soc Echocardiogr 2006;19:1458-61.
7. Fedak PW, McCarthy PM, Bonow RO. Evolving concepts and technologies in mitral valve repair. Circulation 2008;117: 963-74.
8. Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58:2183-9.
9. Feldman T Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
10. Franzen O, van der Heyden J, Baldus S, et al. MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-76.
11. Pleger ST, Mereles D, Schulz-Schonhagen M, et al. Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Am J Cardiol 2011;108:1478-82.
12. Treede H, Schirmer J, Rudolph V, et al. A heart team's perspective on interventional mitral valve repair: percutaneous clip implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patients. J Thorac Cardiovasc Surg 2012;143:78-84.
13. Van den Branden BJ, Swaans MJ, Post MC, et al. Percutaneous edge-to-edge mitral valve repair in high-surgical-risk patients: do we hit the target? JACC Cardiovasc Interv 2012;5:105-11.
14. van den Heuvel AF, Alfieri O, Mariani MA. MitraClip in end-stage heart failure: a realistic alternative to surgery? Eur J Heart Fail 2011;13:472-4.
15. Whitlow PL, Feldman T Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (endovascular valve edge-to-edge repair) High Risk Study. J Am Coll Cardiol 2012;59:130-9.
16. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847.
17. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96.
18. World Health Organization. International Statistical Classification of Diseases and Related Health Problems; 2012. Available at: http://apps.who.int/classifications/icd10/browse/ 2010/en [accessed date: 14 August 2012].
19. Assurance Maladie. Classification commune des actes médicaux (CCAM); 2012. Available at: http://www.ameli.fr/accueil-de-la-ccam/trouver-un-acte/index.php [accessed date: 14 August 2012].
20. Direction de la recherche de l'évaluation et des statistiques (DREES). Redressements du programme de médicalisation des systèmes d'informations (PMSI); 2012. Available at: http://www.drees.sante.gouv.fr/redressements-du-programme-de-medicalisation-des-systemes-d-informations-pmsi, 5334.html [accessed date: 03 July 2012].
21. L'Assurance Maladie en ligne; 2013. Available at: http://www.ameli.fr/
22. Gammie JS, O'Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 2007;115:881-7.
23. Geidel S, Lass M, Krause K, et al. Early and late results of restrictive mitral valve annuloplasty in 121 patients with cardiomyopathy and chronic mitral regurgitation. Thorac Cardiovasc Surg 2008;56:262-8.
24. Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 2004;77:1966-77.
25. Christenson JT, Kalangos A. Economic impact of mitral valve plasty versus replacement for mitral valve insufficiency. J Cardiovasc Surg (Torino) 2003;44:163-6.
26. Cope JT, Kaza AK, Reade CC, et al. A cost comparison of heart transplantation versus alternative operations for cardiomyopathy. Ann Thorac Surg 2001;72:1298-305.
27. Lancellotti P, Rosenhek R, Pibarot P, et al. ESC Working Group on valvular heart disease position paper -heart valve clinics: organization, structure, and experiences. Eur Heart J 2013;34:1597-606.
28. Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009;87:1431-7 [discussion 7-9].
29. Beresniak A, Sabatier B, Achouh P, Menasche P, Fabiani JN. Cost-effectiveness of mitral valve repair versus replacement by biologic or mechanical prosthesis. Ann Thorac Surg 2013;95:98-104.
30. Taramasso M, Denti P, Buzzatti N, et al. Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience. Eur J Cardiothorac Surg 2012;42:920-6.